The Chernin Group and Elysian Park led a $100m Series C round in Oura.

The Chernin Group and Elysian Park, a venture capital firm, led a $100m Series C funding round in Oura Health, a wearables startup. New investors include Temasek, JAZZ Venture Partners and Eisai, joining existing investors Forerunner Ventures, Square, MSD Capital, Marc Benioff, Lifeline Ventures, Metaplanet Holdings and Next Ventures. “The wearables industry is transitioning from activity trackers to health platforms that can improve people’s lives. Oura focused first on sleep because it’s a daily habit, and lack of sleep has been linked to worsening health conditions including diabetes, cardiac disease, Alzheimer’s, cancer, poor mental health, and more," Harpreet Singh Rai, Oura CEO.